After approval by the FDA, AVT03 is expected to be supplied in a single-dose prefilled syringe containing 60 mg in a 1 ml solution, as well as a 120 mg/1.7 ml solution in a single-dose vial.
In an effort to guarantee "the ongoing quality, safety, nutritional adequacy, and resilience of the domestic infant formula ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback